Skip to main content

Table 1 SNPs included in the pubertal development genetic risk score in the ProtecT study

From: Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

SNP

Nearest gene (distance)

Chr

Positiona

Tanner stage decreasing/other allele

Tanner stage decreasing allele frequency (ProtecT controls)b

Tanner stage decreasing allele frequency (CEU)

Hardy–Weinberg equilibrium

P value

Gene function

rs2274465

KDM4A

1

44121557

C/G

0.664

0.676

0.9

Histone demethylation

rs6427782

NR5A2 (+198 kb)

1

199798339

A/G

0.510

0.556

0.005

DNA binding/steroid hormone receptor activity

rs6762477

RBM6

3

50093209

A/G

0.547

0.551

0.6

Regulation of alternative splicing

rs2153127

LIN28B (+36 kb)

6

105348544

T/C

0.530

0.515

0.8

Cell reprogramming

rs7759938

LIN28B (+6 kb)

6

105378954

C/T

0.318

0.373

1.0

Cell reprogramming

rs7821178

PEX2 (–181 kb)

8

78093837

C/A

0.665

0.658

0.1

Peroxisome biogenesis

rs10453225

TMEM38B (–381 kb)

9

108920220

G/T

0.681

0.700

0.2

Maintenance of intracellular calcium release

rs2090409

TMEM38B (–428 kb)

9

108967088

C/A

0.680

0.688

0.3

Maintenance of intracellular calcium release

rs10739221

TMEM38B (–522 kb)

9

109060830

C/T

0.772

0.770

0.5

Maintenance of intracellular calcium release

rs1324913

KLF12

13

74635588

T/G

0.338

0.312

0.6

Transcription factor/gene expression regulation

rs12915845

DET1

15

89042467

C/T

0.587

0.582

0.1

Development regulation

rs246185

MKL2 (–35 kb)

16

14395432

C/T

0.313

0.300

0.6

Regulation of immediate early genes/muscle genes

rs12446632

GPRC5B (–38 kb)

16

19935389

A/G

0.146

0.127

0.8

Modulation of insulin secretion

  1. aPosition based on GRCh37.p13 assembly
  2. b n = 1,791